EULAV Asset Management’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-16,500
| Closed | -$1.32M | – | 238 |
|
|
2021
Q1 | $1.32M | Hold |
16,500
| – | – | 0.04% | 222 |
|
|
2020
Q4 | $1.3M | Hold |
16,500
| – | – | 0.03% | 226 |
|
|
2020
Q3 | $725K | Hold |
16,500
| – | – | 0.02% | 240 |
|
|
2020
Q2 | $730K | Hold |
16,500
| – | – | 0.02% | 241 |
|
|
2020
Q1 | $592K | Sell |
16,500
-10,000
| -38% | -$569K | 0.02% | 237 |
|
|
2019
Q4 | $1.88M | Hold |
26,500
| – | – | 0.06% | 214 |
|
|
2019
Q3 | $1.98M | Hold |
26,500
| – | – | 0.07% | 215 |
|
|
2019
Q2 | $2.14M | Sell |
26,500
-13,400
| -34% | -$942K | 0.08% | 209 |
|
|
2019
Q1 | $2.67M | Hold |
39,900
| – | – | 0.11% | 181 |
|
|
2018
Q4 | $2.97M | Hold |
39,900
| – | – | 0.15% | 156 |
|
|
2018
Q3 | $3.67M | Hold |
39,900
| – | – | 0.16% | 151 |
|
|
2018
Q2 | $3.92M | Hold |
39,900
| – | – | 0.18% | 143 |
|
|
2018
Q1 | $4.45M | Hold |
39,900
| – | – | 0.21% | 143 |
|
|
2017
Q4 | $4.11M | Hold |
39,900
| – | – | 0.19% | 151 |
|
|
2017
Q3 | $3.76M | Buy |
39,900
+400
| +1% | +$31.6K | 0.18% | 158 |
|
|
2017
Q2 | $3.08M | Buy |
39,500
+6,000
| +18% | +$451K | 0.15% | 175 |
|
|
2017
Q1 | $2.68M | Hold |
33,500
| – | – | 0.14% | 193 |
|
|
2016
Q4 | $2.64M | Buy |
33,500
+5,400
| +19% | +$420K | 0.14% | 196 |
|
|
2016
Q3 | $2.19M | Buy |
28,100
+7,100
| +34% | +$515K | 0.12% | 199 |
|
|
2016
Q2 | $1.44M | Buy |
+21,000
| New | +$1.45M | 0.08% | 229 |
|
EULAV Asset Management's CMD Position: Q2 2021 in Review
EULAV Asset Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 16,500 shares — an estimated $1.32M sold.
EULAV Asset Management first reported a position in CMD in Q2 2016 and held it in 20 quarters. The position peaked at $4.45M in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- EULAV Asset Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- EULAV Asset Management sold 16,500 Cantel Medical Corporation shares in Q2 2021, an estimated $1.32M.
- EULAV Asset Management first reported a position in Cantel Medical Corporation in Q2 2016 and held it in 20 quarters.
- EULAV Asset Management's Cantel Medical Corporation position peaked at $4.45M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on EULAV Asset Management's 13F filing for Q2 2021, filed 6 Aug 2021.